KEW Inc.

At KEW our mission is to revolutionize cancer care by empowering oncologists to access and apply the latest genomic insights to design optimal, individualized treatment approaches for patients. We recognize that delivering patient-specific genetic and genomic data to the physician is just the first step in aiding critical decision-making. Our goal is to provide oncologists practical, action-oriented solutions by coupling comprehensive patient-specific genomic data, identified through our sophisticated genomic test, CancerPlex‚Ą†, together with evidence-based information about approved and emerging therapies, presented through our proprietary TPx Treatment Pathways, to help guide treatment decisions and advance optimal patient care.

KEW Inc. is headquartered in Cambridge, MA.


Arsenal Capital Management – St Louis | KEW Inc.
class="pirenko_portfolios-template-default single single-pirenko_portfolios postid-173 samba_theme samba_left_nav samba_left_align samba_responsive wpb-js-composer js-comp-ver-5.1.1 vc_responsive"